UAB "Pharm House" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,063,396 |
210,991 |
291,583 |
248,302 |
49,266 |
47.50 |
23.35 |
489,528 |
244,502 |
78,582 |
649,989 |
2023 |
---|
1,663,572 |
308,640 |
492,536 |
419,560 |
77,840 |
45.23 |
25.22 |
589,658 |
172,857 |
69,034 |
689,824 |
2024 |
---|
2,203,946 |
367,324 |
635,235 |
539,645 |
89,941 |
53.80 |
24.49 |
894,008 |
513,615 |
198,056 |
1,199,435 |
Register and
explore Okredo data2024 |
---|
2,203,946 |
367,324 |
635,235 |
539,645 |
89,941 |
53.80 |
24.49 |
894,008 |
513,615 |
198,056 |
1,199,435 |
Register and
explore Okredo data2024
Turnover (€)
2,203,946 €32 % *
Sales per employee (€)
367,324 €19 % *
Profit before tax (€)
635,235 €29 % *
Net Profit (€)
539,645 €29 % *
Profit per employee (€)
89,941 €16 % *
Total profitability (%)
53.80 %18.95 % *
Net profitability (%)
24.49 %-2.89 % *
Equity (€)
894,008 €52 % *
Amounts Payable And Liabilities (€)
513,615 €197 % *
Non-current Assets (€)
198,056 €187 % *
CurrentAssets (€)
1,199,435 €74 % *